“…Generally, this is accomplished by conducting general preclinical safety studies to uncover potential toxic effects of drug in question (19) . With the above considerations, the present study was aimed to evaluate the acute and subacute (repeated dose, 28 days) toxicity of novel herbal formulation developed at our laboratory in Wistar rats.…”